Square Pharmaceuticals PLC officially launched commercial operations at its newest oncology formulation manufacturing plant in Kaliakair on Thursday.
Equipped with robotic isolator lines and high-containment technology, the facility will produce 32 essential chemotherapy medications, reducing patient costs by up to 60% compared to imported equivalents.